We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
101
Microchip Technology
MCHP
$42.8B
$18.1M 0.23%
418,712
+96,432
+30% +$4.28M
NFLX icon
102
Netflix
NFLX
$292B
$18.1M 0.23%
493,740
+60,100
+14% +$2.17M
AERI
103
DELISTED
Aerie Pharmaceuticals
AERI
$17.8M 0.22%
604,800
CBRE icon
104
CBRE Group
CBRE
$40.8B
$17.5M 0.22%
319,619
-13,091
-4% -$651K
INTU icon
105
Intuit
INTU
$81.1B
$17.3M 0.22%
66,478
-7,686
-10% -$1.95M
LUV icon
106
Southwest Airlines
LUV
$22.1B
$17.3M 0.22%
341,849
+73,148
+27% +$3.79M
BKNG icon
107
Booking.com
BKNG
$138B
$17.2M 0.21%
230,475
-39,450
-15% -$2.83M
DFS
108
DELISTED
Discover Financial Services
DFS
$17.1M 0.21%
206,965
-21,114
-9% -$1.64M
MCD icon
109
McDonald's
MCD
$188B
$17M 0.21%
82,307
+12,270
+18% +$2.43M
VLO icon
110
Valero Energy
VLO
$89.8B
$16.9M 0.21%
182,797
+67,741
+59% +$5.59M
ARNA
111
DELISTED
Arena Pharmaceuticals Inc
ARNA
$16.5M 0.21%
282,800
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
$16.4M 0.2%
1,108,123
+326,500
+42% +$5.9M
VRNS icon
113
Varonis Systems
VRNS
$5.25B
$16.3M 0.2%
792,060
-29,196
-4% -$627K
CVX icon
114
Chevron
CVX
$388B
$16.3M 0.2%
131,306
+56,758
+76% +$6.86M
MRTX
115
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$16.1M 0.2%
157,000
+44,000
+39% +$3.43M
TCF
116
DELISTED
TCF Financial Corporation
TCF
$16M 0.2%
771,203
+314,039
+69% +$6.56M
TRMB icon
117
Trimble
TRMB
$12.3B
$15.8M 0.2%
352,754
-212,316
-38% -$8.82M
SPGI icon
118
S&P Global
SPGI
$126B
$15.7M 0.2%
69,250
+42,786
+162% +$9.35M
EXEL icon
119
Exelixis
EXEL
$13.9B
$15.7M 0.2%
737,342
+24,200
+3% +$507K
XLRN
120
DELISTED
Acceleron Pharma
XLRN
$15.6M 0.19%
381,948
+141,448
+59% +$5.86M
WM icon
121
Waste Management
WM
$95.9B
$15.5M 0.19%
110,948
+9,623
+9% +$1.04M
BAC icon
122
Bank of America
BAC
$435B
$15.4M 0.19%
533,628
-52,669
-9% -$1.52M
TRCO
123
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$15.3M 0.19%
332,834
+223,584
+205% +$10.3M
SYK icon
124
Stryker
SYK
$127B
$15.2M 0.19%
69,401
+5,129
+8% +$980K
FTV icon
125
Fortive
FTV
$19B
$15.2M 0.19%
296,053
-26,948
-8% -$1.4M

Similar funds

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.